STE

SEC source: 0001209191-19-033943 · doc4.xml · nonDerivative · entry 1

deZwaan Michiel · CIK 0001616395 · V.P., Human Resources & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,122

F1 · shares: All 2,224 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023.

F2 · balance_after: All 8,122 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,378 on October 4, 2021; 2,520 on May 31, 2022 and 2,224 on May 31, 2023.

SEC source: 0001209191-19-033944 · doc4.xml · derivative · entry 2

Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,244

Underlying: Ordinary Shares · 19,244 shares

Expires 2029-05-31

F3 · derivative.exercise_date: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023.

SEC source: 0001209191-19-033944 · doc4.xml · nonDerivative · entry 1

Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,685

F1 · shares: All 1,112 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 834 on May 31, 2022 and 278 on May 31, 2023.

F2 · balance_after: 9,976 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 4,500 on June 1, 2021; 1,864 on May 31, 2022; 834 on May 31, 2022; and 278 on May 31, 2023.

SEC source: 0001209191-19-033941 · doc4.xml · derivative · entry 2

Coward Adrian Vincent · CIK 0001657350 · Sr. V P, Healthcare Spec Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,484

Underlying: Ordinary Shares · 7,484 shares

Expires 2029-05-31

F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,871 on June 1, 2020; 1,871 on June 1, 2021; 1,871 on May 31, 2022 and 1,871 on May 31, 2023.

SEC source: 0001209191-19-033941 · doc4.xml · nonDerivative · entry 1

Coward Adrian Vincent · CIK 0001657350 · Sr. V P, Healthcare Spec Serv

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,119

F1 · shares: All 1,296 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,296 on May 31, 2023.

F2 · balance_after: 11,748 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,028 on October 1, 2019; 3,000 on June 1, 2021; 1,424 on May 31, 2022 and 1,296 on May 31, 2023.

SEC source: 0001209191-19-033932 · doc4.xml · derivative · entry 3

Burton Karen L · CIK 0001697095 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,880

Underlying: Ordinary Shares · 5,880 shares

Expires 2029-05-31

F4 · price: This option becomes exercisable as follows: 1,470 on June 1, 2020; 1,470 on June 1, 2021; 1,470 on May 31, 2022 and 1,470 on May 31, 2023.

F4 · derivative.exercise_date: This option becomes exercisable as follows: 1,470 on June 1, 2020; 1,470 on June 1, 2021; 1,470 on May 31, 2022 and 1,470 on May 31, 2023.

SEC source: 0001209191-19-033932 · doc4.xml · nonDerivative · entry 1

Burton Karen L · CIK 0001697095 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,195

F1 · shares: All 1,020 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 765 on May 31, 2022 and 255 on May 31, 2023.

SEC source: 0001209191-19-033939 · doc4.xml · derivative · entry 2

Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,868

Underlying: Ordinary Shares · 28,868 shares

Expires 2029-05-31

F3 · derivative.exercise_date: This option becomes exercisable as follows: 7,217 on June 1, 2020; 7,217 on June 1, 2021; 7,217 on May 31, 2022 and 7,217 on May 31, 2023.

SEC source: 0001209191-19-033939 · doc4.xml · nonDerivative · entry 1

Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,975

F1 · shares: All 5,008 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,008 on May 31, 2023.

F2 · balance_after: 20,468 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; and 5,008 on May 31, 2023.

SEC source: 0001209191-19-033929 · doc4.xml · derivative · entry 4

Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,420

Underlying: Ordinary Shares · 3,420 shares

Expires 2029-05-31

F5 · price: This option becomes exercisable as follows: 855 on June 1, 2020; 855 on June 1, 2021; 855 on May 31, 2022 and 855 on May 31, 2023.

F5 · derivative.exercise_date: This option becomes exercisable as follows: 855 on June 1, 2020; 855 on June 1, 2021; 855 on May 31, 2022 and 855 on May 31, 2023.

SEC source: 0001209191-19-033929 · doc4.xml · nonDerivative · entry 3

Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,578

F3 · shares: All 592 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 148 on June 1, 2020; 148 on June 1, 2021; 148 on May 31, 2022 and 148 on May 31, 2023.

F4 · balance_after: 4,146 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 148 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021; 148 on June 1, 2021; 393 on May 31, 2022; 148 on May 31, 2022 and 148 on May 31, 2023.

SEC source: 0001209191-19-033929 · doc4.xml · nonDerivative · entry 2

Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,986

F2 · shares: 118 shares were withheld from the 393 restricted shares that vested on May 31, 2019. These 118 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 393 ordinary shares were awarded to Ms. Bardwell on May 31, 2018 as part of an award of 1,572 restricted shares. These vested shares were valued at the NYSE closing market price on May 31, 2019. The remaining restrictions on these ordinary shares lapse as follows: 393 on June 1, 2020; 393 on June 1, 2021 and 393 on May 31, 2022.

SEC source: 0001209191-19-033948 · doc4.xml · derivative · entry 13

Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Underlying: Ordinary Shares · 119,000 shares

Expires 2024-05-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.

F3 · derivative.exercise_date: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.

SEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 5

Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,350

F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019.

F6 · price: Price reflects a weighted average sale price for multiple transactions ranging from $134.53 to $134.69 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 4

Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,750

F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019.

F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $133.54 to $134.50 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 3

Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,672

F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019.

F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $132.53 to $133.52 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 2

Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: This exercise and sale of a total of 60,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on May 15, 2019.

F3 · shares: This option to purchase 119,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 119,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.

SEC source: 0001209191-19-033948 · doc4.xml · nonDerivative · entry 1

Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,350

F1 · shares: 1,860 shares were withheld from the 4,000 restricted shares that vested on May 30, 2019. These 1,860 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,000 ordinary shares were awarded to Mr. Rosebrough on May 30, 2017 as part of an award of 16,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2019. The remaining restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2020; and 4,000 on May 30, 2021.

SEC source: 0001209191-19-033929 · doc4.xml · nonDerivative · entry 1

Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,104

F1 · shares: 150 shares were withheld from the 500 restricted shares that vested on May 30, 2019. These 150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Ms. Bardwell on May 30, 2017 as part of an award of 2,000 restricted shares. These vested shares were valued at the NYSE closing market price on May 30, 2019. The remaining restrictions on these ordinary shares lapse as follows: 500 on May 30, 2020 and 500 on May 30, 2021.

SEC source: 0001209191-19-033440 · doc4.xml · nonDerivative · entry 1

Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,573

F1 · shares: 2,291 shares were withheld from the 7,000 restricted shares that vested on May 28, 2019. These 2,291 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 7,000 ordinary shares were awarded to Mr. Khan on August 27, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: 8,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022.

SEC source: 0001209191-19-033437 · doc4.xml · nonDerivative · entry 1

Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,967

F1 · shares: 1,493 shares were withheld from the 5,000 restricted shares that vested on May 28, 2019. These 1,493 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 5,000 ordinary shares were awarded to Mr. Carestio on August 10, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: 15,460 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 3,000 on October 1, 2019; 5,500 on June 1, 2021; 2,712 on May 31, 2022 and 1,748 on October 3, 2022.

SEC source: 0001209191-19-033446 · doc4.xml · nonDerivative · entry 1

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,852

F1 · shares: 944 shares were withheld from the 3,000 restricted shares that vested on May 28, 2019. These 944 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,000 ordinary shares were awarded to Mr. Zangerle on August 10, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: 16,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022.

SEC source: 0001209191-19-033445 · doc4.xml · nonDerivative · entry 1

TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,785

F1 · shares: 2,673 shares were withheld from the 7,000 restricted shares that vested on May 28, 2019. These 2,673 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 7,000 ordinary shares were awarded to Mr. Tokich on August 10, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: 18,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022.

SEC source: 0001209191-19-033444 · doc4.xml · nonDerivative · entry 1

Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,101

F1 · shares: 150 shares were withheld from the 500 restricted shares that vested on May 28, 2019. These 150 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 500 ordinary shares were awarded to Mr. Tamaro on May 28, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: 1,896 of these ordinary shares are restricted. The restrictions on the ordinary shares lapse as follows: 600 on October 1, 2019; 400 on June 1, 2020; 412 on June 1, 2021 and 484 on May 31, 2022.

SEC source: 0001209191-19-033443 · doc4.xml · nonDerivative · entry 1

Rosebrough Walter M Jr · CIK 0001413087 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,210

F1 · shares: 1,685 shares were withheld from the 3,625 restricted shares that vested on May 28, 2019. These 1,685 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 3,625 ordinary shares were awarded to Mr. Rosebrough on August 10, 2015 as part of an award of 14,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: These 47,210 ordinary shares are held by the reporting person as trustee of a revocable trust established for his benefit. 33,750 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,000 on May 30, 2019; 3,097 on May 31, 2019; 4,681 on June 3, 2019; 4,681 on June 1, 2020; 4,000 on June 1, 2020; 3,097 on June 1, 2020; 4,000 on June 1, 2021; 3,097 on June 1, 2021 and 3,097 on May 31, 2022.

SEC source: 0001209191-19-033442 · doc4.xml · nonDerivative · entry 2

Majors Cary L · CIK 0001776271 · VP, N America Com Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,971

F2 · shares: 450 shares were withheld from the 1,500 restricted shares that vested on May 28, 2019. These 450 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,500 ordinary shares were awarded to Mr. Majors on August 10, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F3 · balance_after: 14,520 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on October 1, 2019; 2,500 on June 1, 2020; 6,500 on May 31, 2021; and 2,520 on May 31, 2022

SEC source: 0001209191-19-033442 · doc4.xml · nonDerivative · entry 1

Majors Cary L · CIK 0001776271 · VP, N America Com Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,421

F1 · shares: 599 shares were withheld from the 2,000 restricted shares that vested on May 28, 2019. These 599 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,000 ordinary shares were awarded to Mr. Majors on May 28, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

SEC source: 0001209191-19-033435 · doc4.xml · nonDerivative · entry 1

Burton Karen L · CIK 0001697095 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,175

F1 · shares: 229 shares were withheld from the 764 restricted shares that vested on May 28, 2019. These 229 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 764 ordinary shares were awarded to Ms. Burton on May 28, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: 6,252 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 700 on October 1, 2019; 1,220 on June 1, 2020; 3,000 on June 1, 2021; and 1,332 on May 31, 2022.

SEC source: 0001209191-19-033432 · doc4.xml · nonDerivative · entry 1

Bardwell Kathleen · CIK 0001532367 · Sr.V. P. & C.C.O.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,254

F1 · shares: 187 shares were withheld from the 625 restricted shares that vested on May 28, 2019. These 187 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 625 ordinary shares were awarded to Ms. Bardwell on August 10, 2015 as part of an award of 2,500 restricted shares. These vested shares were valued at the NYSE closing market price on May 28, 2019.

F2 · balance_after: 4,447 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 500 on May 30, 2019; 393 on May 31, 2019; 500 on June 3, 2019; 375 on October 1, 2019; 500 on June 1, 2020; 500 on June 1, 2020; 393 on June 1, 2020; 500 on June 1, 2021; 393 on June 1, 2021 and 393 on May 31, 2022.

SEC source: 0001209191-19-032087 · doc4.xml · derivative · entry 3

Sohi Mohsen · CIK 0001293588 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,133 shares

Expires 2020-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F2 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-032087 · doc4.xml · nonDerivative · entry 2

Sohi Mohsen · CIK 0001293588 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,361

F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $135.92 to $135.96 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-032087 · doc4.xml · nonDerivative · entry 1

Sohi Mohsen · CIK 0001293588 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-030951 · doc4.xml · nonDerivative · entry 1

Wood Michael B · CIK 0001306341 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,631

F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $134.66 to $134.80 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-030369 · doc4.xml · derivative · entry 4

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,609 shares

Expires 2019-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option to purchase 3,609 STERIS plc ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,609 Old STERIS ordinary shares for $28.08 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-030369 · doc4.xml · nonDerivative · entry 2

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $132.22 to $132.28 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-19-030369 · doc4.xml · nonDerivative · entry 1

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,609

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 7

LEWIS DAVID B · CIK 0001136554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,996

Underlying: Ordinary Shares · 13,996 shares

Expires not disclosed

F7 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

F7 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

F7 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,996 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.

SEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 6

LEWIS DAVID B · CIK 0001136554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 436

Underlying: Ordinary Shares · 436 shares

Expires 2028-08-09

F6 · price: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F6 · derivative.exercise_date: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 5

LEWIS DAVID B · CIK 0001136554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 927

Underlying: Ordinary Shares · 927 shares

Expires 2027-08-09

F5 · price: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F5 · derivative.exercise_date: This option to purchase 927 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 927 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 4

LEWIS DAVID B · CIK 0001136554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,218

Underlying: Ordinary Shares · 3,218 shares

Expires 2022-08-03

F4 · price: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F4 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 3

LEWIS DAVID B · CIK 0001136554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,121

Underlying: Ordinary Shares · 3,121 shares

Expires 2021-08-03

F3 · price: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021604 · doc4.xml · derivative · entry 2

LEWIS DAVID B · CIK 0001136554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,133

Underlying: Ordinary Shares · 3,133 shares

Expires 2020-08-04

F2 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F2 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021604 · doc4.xml · nonDerivative · entry 1

LEWIS DAVID B · CIK 0001136554 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,684

F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

SEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 7

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,536

Underlying: Ordinary Shares · 21,536 shares

Expires 2028-05-31

F8 · price: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 21,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F8 · derivative.exercise_date: This option becomes exercisable as follows: 5,384 on May 31, 2019; 5,384 on June 1, 2020; 5,384 on June 1, 2021 and 5,384 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 21,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 6

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Ordinary Shares · 14,000 shares

Expires 2027-05-30

F7 · price: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 14,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F7 · derivative.exercise_date: This option becomes exercisable as follows: 3,500 on May 30, 2018; 3,500 on May 30, 2019; 3,500 on June 1, 2020 and 3,500 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 14,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 5

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Ordinary Shares · 15,000 shares

Expires 2026-06-01

F6 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F6 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 4

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Ordinary Shares · 8,000 shares

Expires 2025-08-10

F5 · price: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F5 · derivative.exercise_date: This option becomes exercisable as follows: 2,000 on May 28, 2016; 2,000 on May 28, 2017; 2,000 on May 28, 2018 and 2,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 8,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option.

SEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 3

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,252

Underlying: Ordinary Shares · 12,252 shares

Expires 2024-05-30

F4 · price: This option to purchase 12,252 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 12,252 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option

F4 · derivative.exercise_date: This option to purchase 12,252 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 12,252 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option

SEC source: 0001209191-19-021616 · doc4.xml · derivative · entry 2

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Ordinary Shares · 3,000 shares

Expires 2023-05-31

F3 · price: This option to purchase 3,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018.

F3 · derivative.exercise_date: This option to purchase 3,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option was initially granted as an option to purchase 6,000 ordinary shares. On January 25, 2019, the reporting person exercised this option for 3,000 ordinary shares pursuant to a Rule 10b5-1 Stock Trading Plan, entered into by the reporting person on November 9, 2018.

SEC source: 0001209191-19-021616 · doc4.xml · nonDerivative · entry 1

Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,796

F1 · shares: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022.

F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F1 · balance_after: 19,136 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020; 6,000 on June 1, 2021 and 3,636 on May 31, 2022.